PCRX•benzinga•
Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate
Summary
Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 14, 2025 by benzinga